InvestorsHub Logo
Followers 275
Posts 36007
Boards Moderated 2
Alias Born 04/05/2012

Re: None

Sunday, 12/08/2019 10:35:27 PM

Sunday, December 08, 2019 10:35:27 PM

Post# of 2793
News article just released folks ~>

https://www.oncnet.com/news/vosaroxin-and-cytarabine-yield-less-toxicity-standard-aml-therapy

Orlando, Florida—Findings being presented at the 2019 ASH Annual Meeting demonstrate that vosaroxin and infusional cytarabine is a safe treatment regimen for newly diagnosed patients with acute myeloid leukemia (AML).

D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.